FDA Adverse Event Injury Summary report: N

VICRYL PLUS ANTIBACTERIAL (POLYGLACTIN 910) SUTURE

MDR report key: 3894790 · Received June 25, 2014

Report

Report Number
2210968-2014-08208
Event Type
Injury
Date Received
June 25, 2014
Date of Event
May 30, 2014
Report Date
June 4, 2014
Manufacturer
ETHICON INC.
Product Code
GAM
PMA / PMN Number
K032420
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS FOR THE POSSIBLE BATCH NUMBERS WAS CONDUCTED AND THE BATCHES MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

(B)(4). NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY. THE ACTUAL DEVICE BATCH NUMBER ASSOCIATED WITH THIS EVENT IS NOT KNOWN. THE INTERNATIONAL AFFILIATE REPORTS THE FOLLOWING POSSIBLE LOT NUMBERS: LOT HBM487; LOT HB5345.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A SURGICAL PROCEDURE ON (B)(6) 2014 AND SUTURE WAS USED TO CLOSE A HORIZONTAL INCISION IN THE PATIENTS ABDOMINAL FASCIA. THE INCISION WAS CLOSED IN KNOTTED SUTURE THROUGH THE FASCIA AND THE OPERATION WAS COMPLETED SUCCESSFULLY. LATER THAT EVENING, THE CLOSED INCISION OPENED AND A RE-OPERATION WAS PERFORMED. THE SURGEON OBSERVED DURING RE-OPERATION, THAT THE KNOTTED SUTURE HAD COME UNTIED. THE SURGEON OPINED THAT DUE TO THE BODY SIZE OF THE PATIENT THERE MIGHT HAVE BEEN MORE TENSION ON THE LIGATION PART THAN USUAL OR THE SUTURE MAY HAVE SPLIT THE FASCIA MOVING THE KNOT WHICH CAUSED THE UNTYING OR THE KNOT WAS NOT APPROPRIATELY TIED IN THE FIRST PLACE. CURRENTLY, THE PATIENT IS IN STABLE CONDITION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
369966 VICRYL PLUS ANTIBACTERIAL (POLYGLACTIN 910) SUTURE SUTURE, ABSORBABLE, SYNTHETIC GAM ETHICON INC. UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention